Stock photos, 360° images, vectors and videos
Filters
Quick filters:
RF2HC88MY–Gastrulation, Gastrula, tri layer stage of embryonic development, endoderm, ectoderm, mesoderm.
RF2FNRTCW–Biological illustration of a stem cell, they can develop into many types of cells in the body. They serve as a repair system for the body.
RF2JKFTM5–This image shows mature iPSCs (induced pluripotent stem cells) derived from retinal pigment epithelium (RPE) cells, magnified by super-resolution conf
RFPR1RKK–Stem cell-derived motor neuron. Coloured scanning electron micrograph (SEM) of a human nerve cell (neuron) that has been derived from an embryonic pluripotent stem cell (ES). Pluripotent stem cells are able to differentiate into any of the 200 cell types in the human body. The type of cell they mature into depends upon the biochemical signals received by the immature cells. This ability makes them a potential source of cells to repair damaged tissue in diseases such as Parkinson's and insulin-dependent diabetes. Magnification: x 1500 when printed 10 centimetres wide.
RM2HP72GA–A researcher works with induced pluripotent stem cells in NCATS' Stem Cell Translation Laboratory ca. October 16 2018
RMRBF9HG–San Diego, California, USA. 9th Oct, 2018. -Master's student DYLAN PHAN checks the development of pluripotent stem cells as part of the 'minibrain' growth process in the Muotri Lab at the University of California San Diego (UCSD) Stem Cell Program. Credit: David Poller/ZUMA Wire/ZUMAPRESS.com/Alamy Live News
RME0CW10–An undated scanning electron microscope handout picture from the Max Planck Institute for Molecular Biomedicine shows human neurons grown from induced pluripotent stem cells in Muenster, Germany. Photo: Mpi Muenster
RMD4H9M1–(L-R) Scientist professors Japanese Shinya Yamanaka, U.S. Irbing Weissman, and German Hans Robert Schoeler pose with their Rober Koch Prizes 2008 in Berlin, Germany, 14 November 2008. Mr. Yamanake was awarded for his ground-breaking research of pluripotent stem cells, Mr. Weissman for his research on phylogenesis and the development of stem cells, and Mr. Schoeler for his research
RMEB4A5T–Tokyo, Japan. 26th Nov, 2014. Masayo Takahashi Project Leader of Laboratory for Retinal Regeneration Center for Developmental Biology, RIKEN speaks at the Foreign Correspondents' Club of Japan on November 26, 2014 in Tokyo, Japan. The leader of the First Ever In-human Clinical Study iPS Cells spoke about the medical future applications of the iPS (induced pluripotent stems) cells. Her team implanted as a first time into the eye of an elderly patient suffering from macular degeneration last September. Takahashi's team and Nobel Prize winner Shinya Yamanaka, who discovered how to create
RMCFX04F–March 15, 2007, San Diego, California, USA Dr. BEVERLY EMERSON of the Salk Institute specializes in how genes are turned on and off. She got the SEED grant so that she can look at human embryonic stem cells to try to find out what genes need to be turned on and off to make them pluripotent, which
RM2EWR4NN–Dr. David DiGiusto directs Stanford's new Laboratory for Cell and Gene Medicine. The university has built a cell manufacturing facility that will generate banks of induced pluripotent stem cells and other specialized tissues such as heart muscle cells, that are derived from stem cells. These cells can be used to test the effects of drugs in a 'clinical trial in a dish' or potentially even used to repair tissues injured by disease or trauma. (Photo by Patrick Tehan/Bay Area News Group/TNS) *** Please Use Credit from Credit Field ***
RMJNNWN2–KYOTO, Japan - A symposium on induced pluripotent stem cells, or iPS cells, which have the potential to grow into various kinds of body cells, was held in Kyoto on Dec. 25, with medical experts taking part. (Kyodo)
RFGM9THE–Confocal microscopy imaging of a quiescent pluripotent stem cell used in regenerative medicine.
RMJNTWF1–ROME, Italy - Shinya Yamanaka, professor at Kyoto University, holds up a certificate for the Balzan Prize in Rome on Nov. 19, 2010, after winning the award for his pioneering work in producing induced pluripotent stem cells, or iPS cells. (Kyodo)
RMD4B712–Stem cells are cooled down after incubation for 8 days at 37 degrees centigrade before being deep frozen in liquid nitogren.
RMJNWKAX–KYOTO, Japan - Kyoto University professor Shinya Yamanaka (R) speaks at a press conference at the university in Kyoto on July 11, 2011. The European Patent Office has approved a patent for Yamanaka's technology for creating induced pluripotent stem cells, or iPSCs. (Kyodo)
RMJNTC7N–KYOTO, Japan - Shinya Yamanaka (R), professor at Kyoto University's Institute for Integrated Cell-Material Sciences, receives the Kyoto Medal of Honor during a ceremony in the city Oct. 15, 2010 for his contribution in the field of induced pluripotent stem cells, or iPS cells. (Kyodo)
RF2JKFTEW–Adult-like heart tissue engineered from human pluripotent stem cells contains transverse tubules, the mark of maturity, visible on immunofluorescent i
RFPR1RKB–Stem cell-derived motor neuron. Coloured scanning electron micrograph (SEM) of a human nerve cell (neuron) that has been derived from an embryonic pluripotent stem cell (ES). Pluripotent stem cells are able to differentiate into any of the 200 cell types in the human body. The type of cell they mature into depends upon the biochemical signals received by the immature cells. This ability makes them a potential source of cells to repair damaged tissue in diseases such as Parkinson's and insulin-dependent diabetes. Magnification: x1500 when printed 10 centimetres wide
RMRBF9DY–San Diego, California, USA. 9th Oct, 2018. -Detail photo from the Muotri Lab. The University of California San Diego (UCSD) Stem Cell Program is using pluripotent stem cells to grow Neanderthal 'minibrains' in the lab. Made with Neanderthal genes, these organoids mimic the cortex, or outer brain, of Neanderthals. Credit: David Poller/ZUMA Wire/ZUMAPRESS.com/Alamy Live News
RMECR3YY–An undated scanning electron microscope handout picture from the Max Planck Institute for Molecular Biomedicine shows human neurons grown from induced pluripotent stem cells in Muenster, Germany. Photo: Mpi Muenster
RMEB4A65–Tokyo, Japan. 26th Nov, 2014. Masayo Takahashi Project Leader of Laboratory for Retinal Regeneration Center for Developmental Biology, RIKEN speaks at the Foreign Correspondents' Club of Japan on November 26, 2014 in Tokyo, Japan. The leader of the First Ever In-human Clinical Study iPS Cells spoke about the medical future applications of the iPS (induced pluripotent stems) cells. Her team implanted as a first time into the eye of an elderly patient suffering from macular degeneration last September. Takahashi's team and Nobel Prize winner Shinya Yamanaka, who discovered how to create
RF2JKFTC3–NIH National Eye Institute (NEI) researchers have developed the first patient-derived stem cell model to study eye conditions linked to oculocutaneous
RM2BFDY2W–A technician in a germ-free laboratory using an electronic pipette to transfer fibroblast cells into petri dishes before they are placed into an incub
RM2EP6698–Shinya Yamanaka (L) and Chika Yamanaka attend the eighth annual Breakthrough Prize – the “Oscars of Science”, on Sunday, November 3, at NASA Ames Research Center in Moffett Field, California. (Photo by Yichuan Cao/Sipa USA)
RMJNTC7P–KYOTO, Japan - Shinya Yamanaka, professor at Kyoto University, speaks about his joy in receiving the Kyoto Medal of Honor in the city Oct. 15, 2010. Yamanaka, who developed a technology to generate induced pluripotent stem cells, or iPS cells, said helping patients would be his way of returning the favor. (Kyodo)
RME5RT8H–Apheresis machine processing peripheral blood stem cell (PBSC) donation, Centre de transfusion sanguine des armées (CTSA) in
RMJP4TX0–KOBE, Japan - The operation room of the Institute of Biomedical Research and Innovation Hospital in Kobe, western Japan, is seen on Sept. 10, 2014. The world's first surgery to implant retinal tissue derived from induced pluripotent stem cells into a human body was performed there in September 2014. (Kyodo)
RFPR1RMM–Stem cell-derived motor neuron. Coloured scanning electron micrograph (SEM) of a human nerve cell (neuron) that has been derived from an embryonic pluripotent stem cell (ES). Pluripotent stem cells are able to differentiate into any of the 200 cell types in the human body. The type of cell they mature into depends upon the biochemical signals received by the immature cells. This ability makes them a potential source of cells to repair damaged tissue in diseases such as Parkinson's and insulin-dependent diabetes. Magnification: x1500 when printed 10 centimetres wide.
RMJP4CEA–TOKYO, Japan - Kyoto University professor Shinya Yamanaka (C), co-winner of the 2012 Nobel Prize in Physiology or Medicine 'for the discovery that mature cells can be reprogrammed to become pluripotent,' delivers a speech at the headquarters of the ruling Liberal Democratic Party in Tokyo on June 4, 204. (Kyodo)
RMRBF9JA–San Diego, California, USA. 9th Oct, 2018. -Detail photo from the Muotri Lab. The University of California San Diego (UCSD) Stem Cell Program is using pluripotent stem cells to grow Neanderthal 'minibrains' in the lab. Made with Neanderthal genes, these organoids mimic the cortex, or outer brain, of Neanderthals. Credit: David Poller/ZUMA Wire/ZUMAPRESS.com/Alamy Live News
RMDAK0WK–HANDOUT - An undated optical microscope handout picture from the Max Planck Institute for Molecular Biomedicine shows a colony of induced, reprogrammed pluripotent human stem cells in Muenster, Germany. Numerous scientists at the institute of the University of Muenster are involved in stem cell research. Photo: Mpi Muenster
RMJP47D1–KYOTO, Japan - A clean room set up at Kyoto University Hospital's Clinical Research Center for Medical Equipment Development to produce large quantities of platelets for blood transfusions from induced pluripotent stem cells, also known as iPS cells, is shown to the media on March 17, 2014, a day before it officially begins operations. (Kyodo)
RMEB4A66–Tokyo, Japan. 26th Nov, 2014. Masayo Takahashi Project Leader of Laboratory for Retinal Regeneration Center for Developmental Biology, RIKEN speaks at the Foreign Correspondents' Club of Japan on November 26, 2014 in Tokyo, Japan. The leader of the First Ever In-human Clinical Study iPS Cells spoke about the medical future applications of the iPS (induced pluripotent stems) cells. Her team implanted as a first time into the eye of an elderly patient suffering from macular degeneration last September. Takahashi's team and Nobel Prize winner Shinya Yamanaka, who discovered how to create
RM2BFDY2B–A technician in a germ-free laboratory using an electronic pipette to transfer fibroblast cells into petri dishes before they are placed into an incub
RMT4A2BN–Tel Aviv, Israel. 15th April, 2019. A 3D printer is in the process of printing a human heart. Tel Aviv University researchers have printed the world’s first 3D vascularised engineered heart including cells, blood vessels, ventricles and chambers using a patient’s own cells and biological materials. Until now, scientists in regenerative medicine have been successful in printing only simple tissues without blood vessels. Scientists in the laboratory of Prof. Credit: Nir Alon/Alamy Live News
RMD9WE37–Umbilical cord blood stem cell harvesting Bag placental blood Obstetrics and gynaecology department Limoges hospital France.
RME5RT8G–Peripheral blood stem cell (PBSC) donation by apheresis, Centre de transfusion sanguine des armées (CTSA) in Clamart, France.
RMRBF9EE–San Diego, California, USA. 9th Oct, 2018. -DR. ALYSSON MUOTRI, Director of the University of California San Diego (UCSD) Stem Cell Program, is using pluripotent stem cells to grow Neanderthal 'minibrains' in the lab. Dr. Muotri in his office, just steps away from the Black's Beach surf break. Credit: David Poller/ZUMA Wire/ZUMAPRESS.com/Alamy Live News
RMDAK0TX–HANDOUT - An undated scanning electron microscope handout picture from the Max Planck Institute for Molecular Biomedicine shows human neurons grown from induced pluripotent stem cells in Muenster, Germany. Numerous scientists at the institute of the University of Muenster are involved in stem cell research. Photo: Mpi Muenster
RMJP47D2–KYOTO, Japan - A clean room set up at Kyoto University Hospital's Clinical Research Center for Medical Equipment Development to produce large quantities of platelets for blood transfusions from induced pluripotent stem cells, also known as iPS cells, is shown to the media on March 17, 2014, a day before it officially begins operations. (Kyodo)
RMEB4A6F–Tokyo, Japan. 26th Nov, 2014. Masayo Takahashi Project Leader of Laboratory for Retinal Regeneration Center for Developmental Biology, RIKEN speaks at the Foreign Correspondents' Club of Japan on November 26, 2014 in Tokyo, Japan. The leader of the First Ever In-human Clinical Study iPS Cells spoke about the medical future applications of the iPS (induced pluripotent stems) cells. Her team implanted as a first time into the eye of an elderly patient suffering from macular degeneration last September. Takahashi's team and Nobel Prize winner Shinya Yamanaka, who discovered how to create
RMJP2ADA–KYOTO, Japan - Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, holds a press conference at the university in Kyoto on March 1, 2014, following revelations that the university's laboratory conducting experiments on induced pluripotent stem cells has been warned by the science ministry about its careless control of genetically engineered mice. (Kyodo)
RM2BFDY22–A technician in a germ-free laboratory using an electronic pipette to transfer fibroblast cells into petri dishes before they are placed into an incub
RMT4A2BK–Tel Aviv, Israel. 15th April, 2019. A 3D printer is in the process of printing a human heart. Tel Aviv University researchers have printed the world’s first 3D vascularised engineered heart including cells, blood vessels, ventricles and chambers using a patient’s own cells and biological materials. Until now, scientists in regenerative medicine have been successful in printing only simple tissues without blood vessels. Scientists in the laboratory of Prof. Credit: Nir Alon/Alamy Live News
RMD9WE3G–Umbilical cord blood stem cell harvesting Bag placental blood Obstetrics and gynaecology department Limoges hospital France.
RMRBF9DR–San Diego, California, USA. 9th Oct, 2018. -DR. ALYSSON MUOTRI, Director of the University of California San Diego (UCSD) Stem Cell Program, is using pluripotent stem cells to grow Neanderthal 'minibrains' in the lab. Dr. Muotri in his office, just steps away from the Black's Beach surf break. Credit: David Poller/ZUMA Wire/ZUMAPRESS.com/Alamy Live News
RMEB4A6A–Tokyo, Japan. 26th Nov, 2014. Masayo Takahashi Project Leader of Laboratory for Retinal Regeneration Center for Developmental Biology, RIKEN speaks at the Foreign Correspondents' Club of Japan on November 26, 2014 in Tokyo, Japan. The leader of the First Ever In-human Clinical Study iPS Cells spoke about the medical future applications of the iPS (induced pluripotent stems) cells. Her team implanted as a first time into the eye of an elderly patient suffering from macular degeneration last September. Takahashi's team and Nobel Prize winner Shinya Yamanaka, who discovered how to create
RMJP2AD6–KYOTO, Japan - Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, holds a press conference at the university in Kyoto on March 1, 2014, following revelations that the university's laboratory conducting experiments on induced pluripotent stem cells has been warned by the science ministry about its careless control of genetically engineered mice. (Kyodo)
RMJNWY90–KYOTO, Japan - Kyoto University professor Shinya Yamanaka, who has developed induced pluripotent stem cell, or iPSC, technologies, speaks at a press conference in Kyoto on Feb. 1, 2011, after U.S. venture iPierian Inc. assigned its patent estate for iPSCs to Kyoto University in a bid to avoid a dispute with Yamanaka. (Kyodo)
RMJNNWN5–KYOTO, Japan - Shinya Yamanaka, a professor at Kyoto University's Institute for Frontier Medical Sciences, gives a lecture at a symposium on induced pluripotent stem cells, or iPS cells, which have the potential to grow into various kinds of body cells, at a hotel in Kyoto on Dec. 25. Yamanaka is the world's first scientist to have created iPS cells. (Kyodo)
RMJP2AD4–KYOTO, Japan - Shinya Yamanaka (R), who heads Kyoto University's Center for iPS Cell Research and Application, apologizes during a press conference at the university in Kyoto on March 1, 2014, following revelations that the university's laboratory conducting experiments on induced pluripotent stem cells has been warned by the science ministry about its careless control of genetically engineered mice. (Kyodo)
RMJP13DH–TOKYO, Japan - Kyoto University professor Shinya Yamanaka (L), a 2012 Nobel Prize in medicine laureate, visits education minister Hakubun Shimomura (R) at the ministry in Tokyo on Jan. 10, 2013. The minister pledged government support of 110 billion yen over 10 years for research on induced pluripotent stem cells, or iPS cells. (Kyodo)
RMJP0XN4–KYOTO, Japan - A Japanese Red Cross Society employee displays a poster at a blood donation center in Kyoto on June 17, 2013, as the group launches a campaign in Kyoto and Osaka urging blood donors to cooperate in an induced pluripotent stem cell stock project spearheaded by iPS cell developer and Nobel Prize winner Shinya Yamanaka. (Kyodo)
RMJNW377–KYOTO, Japan - Shinya Yamanaka, a Kyoto University professor known for developing technologies to generate induced pluripotent stem cells, or iPS cells, receives a thread ball as a memento at the award ceremony in Kyoto on Nov. 10, 2010, for the 2010 Kyoto Prize, an international prize presented by the Inamori Foundation. Yamanaka was recognized for his contributions in the field of biotechnology and medical technology. (Kyodo)
RM2BFDY29–A technician in a germ-free laboratory using an electronic pipette to transfer fibroblast cells into petri dishes before they are placed into an incub
RMRBF9GB–San Diego, California, USA. 9th Oct, 2018. -DR. ALYSSON MUOTRI holds a Neanderthal skull. Muotri, Director of the University of California San Diego (UCSD) Stem Cell Program, is using pluripotent stem cells to grow Neanderthal 'minibrains' in the lab. Made with Neanderthal genes, these organoids mimic the cortex, or outer brain, of Neanderthals. Credit: David Poller/ZUMA Wire/ZUMAPRESS.com/Alamy Live News
RMJP4TX5–OSAKA, Japan - Masayo Takahashi (L), project leader at Riken Center for Developmental Biology, inspects an experiment at Riken's stem cell culture laboratory in Kobe, western Japan, in February 2013. A Japanese team has recently conducted the world's first surgery to implant tissue derived from induced pluripotent stem cells into a human body as part of the clinical study led by Takahashi and others. (Kyodo)
RMEB4A67–Tokyo, Japan. 26th Nov, 2014. Masayo Takahashi Project Leader of Laboratory for Retinal Regeneration Center for Developmental Biology, RIKEN speaks at the Foreign Correspondents' Club of Japan on November 26, 2014 in Tokyo, Japan. The leader of the First Ever In-human Clinical Study iPS Cells spoke about the medical future applications of the iPS (induced pluripotent stems) cells. Her team implanted as a first time into the eye of an elderly patient suffering from macular degeneration last September. Takahashi's team and Nobel Prize winner Shinya Yamanaka, who discovered how to create
RMJP4TM3–KOBE, Japan - Photo taken Sept. 10, 2014, shows the Institute of Biomedical Research and Innovation Hospital in Kobe, western Japan. At the hospital on Sept. 12, a Japanese research team transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s, marking the first time iPS-derived cells have been introduced into a human body by surgery. (Kyodo)
RMT4A2B1–Tel Aviv, Israel. 15th April, 2019. Prof. TAL DVIR, Tel Aviv University, holds up the world's first, completed, 3D printed, vascularised engineered heart, including cells, blood vessels, ventricles and chambers using a patient’s own cells and biological materials. Until now, scientists in regenerative medicine have been successful in printing only simple tissues without blood vessels. Dvir claims study paves the way to a future in which patients will no longer have to wait for transplants nor tackle the obstacles of rejection. Credit: Nir Alon/Alamy Live News
RMJP1D7E–KOBE, Japan - Masayo Takahashi, project leader from the state-backed scientific research institute Riken, speaks at a news conference in Kobe, Hyogo Prefecture, on July 30, 2013. Riken and the Foundation for Biomedical Research and Innovation said that the world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina will begin on August 1, 2013. (Kyodo)
